scispace - formally typeset
B

Byung Sun Min

Researcher at The Catholic University of America

Publications -  403
Citations -  8937

Byung Sun Min is an academic researcher from The Catholic University of America. The author has contributed to research in topics: Chemistry & Antioxidant. The author has an hindex of 43, co-authored 385 publications receiving 7465 citations. Previous affiliations of Byung Sun Min include Catholic University of Daegu & Korea Research Institute of Bioscience and Biotechnology.

Papers
More filters
Journal ArticleDOI

Flavonoid Glycosides from Chromolaena odorata Leaves and Their in vitro Cytotoxic Activity.

TL;DR: Two new flavonoid glycosides, (1, 2), and eleven known compounds, (3-13), were isolated from from a 70% EtOH extract of the leaves of Chromolaena odorata (Asteraceae).
Journal Article

Protein Tyrosine Phosphatase 1B inhibitory Activity of Anthraquinones and Stilbenes

TL;DR: In this article, an in vitro enzyme assay for some anthraquinones and stilbenes isolated from plants was conducted to search for new types of PTP1B inhibitors.
Journal ArticleDOI

Anti-inflammatory and cytotoxic activities of constituents isolated from the fruits of Ziziphus jujuba var. inermis Rehder.

TL;DR: Three new sesquilignans, zijusesquillignans A-C (1-3), together with fifteen known compounds (4-18), were isolated from fruits of Ziziphus jujuba var.
Journal ArticleDOI

Kinetics and molecular docking studies of cholinesterase inhibitors derived from water layer of Lycopodiella cernua (L.) Pic. Serm. (II).

TL;DR: The docking results for complexes with AChE or BChE revealed that inhibitors 4, 7, and 15 stably positioned themselves in several pocket/catalytic domains of the A cholinesterase and BchE residues.
Journal ArticleDOI

Inhibition of C1-Ten PTPase activity reduces insulin resistance through IRS-1 and AMPK pathways

TL;DR: Findings suggest that 15,16-dihydrotanshinone I (DHTS), as a C1-Ten protein tyrosine phosphatase inhibitor, could provide a novel therapeutic strategy for insulin resistance-associated metabolic syndrome through dual targeting of IRS-1 and AMPK.